Nav leads our Boston office and our work in Innovation within the Strategy Practice. He is also a leader in the Pharmaceutical & Medical Products Practice in North America, as well as the McKinsey Center for Government's work with regulatory agencies. Nav brings to his client engagements a deep business expertise in strategy, innovation, operations, business development, and risk. An expert in the use of Six Sigma methodologies for product development and process design, Nav holds 15 patents.
His passions lie at the intersection of science, engineering, medicine, and business. Nav works with pharmaceutical companies to enhance R&D productivity, with contract-research organizations to strengthen performance, and with private-equity players that invest in a variety of science- and medicine-intensive areas.
Nav also spearheads McKinsey's knowledge initiatives on R&D productivity in the pharmaceutical industry and leads our Center for Asset Optimization. He hosts frequent Imagine events that convene cross-sector leaders on cutting-edge topics, such as 3-D printing, commercial applications of drones, and self-driving cars. His recent government work has included helping regulators to enhance their performance and developing tools to help states optimize their IT portfolios.
Before joining McKinsey, in 2001, Nav was a laboratory manager at General Electric, where he helped to design manufacturing processes and to develop new polymetric materials and nanomaterials.
"Exploring the disruptive potential of synthetic biology," McKinsey & Company, June 2016
"What's driving the surge in new drug approvals?," McKinsey & Company, November 2013
"Regulatory excellence," McKinsey Center for Government compendium, October 2013
"New frontiers in pharma R&D investment," McKinsey Quarterly, February 2010
University of Minnesota
PhD, chemical engineering
Rensselaer Polytechnic University
Indian Institute of Technology
BTech, chemical engineering and engineering